Global Outlook of the Hybrid Imaging Market Feb-2017

Global Hybrid Imaging Market 2017-2021
The Hybrid Imaging Market report contains a comprehensive market and vendor landscape in addition
to a SWOT analysis of the key vendors for 2017-2021. The following companies are the key players in the
global hybrid imaging market: GE Healthcare, Mediso, Philips Healthcare, and Siemens Healthcare.
One trend in market is emergence of time of flight-hybrid image systems. The emergence of time of
flight-PET/CT systems is expected to have a positive impact on the market growth, owing to its increased
advantages over conventional systems. For instance, conventional PET scanners produce images by
observing gamma rays created by radioisotopes injected into the body. On the other hand, time of
flight-PET scans measure the time difference between the two rays, which substantially improves the
images produced by the scan.
Time of flight-PET systems incorporate fast photomultipliers, modern electronics, scintillators with high
density, and faster computing power for image reconstruction. This helps in producing accurate and
high-quality images for better diagnosis of chronic conditions. The system allows physicians to measure
tumor metabolism, which reflects tumor aggressiveness. These systems find applications in the areas of
oncology such as lung, esophageal, colon, head and neck cancer, melanomas, and brain tumors. One of
the advanced time of flight PET system is Toshiba's Celesteion, which features 450 ps time of flight
resolution. Such advanced systems will have a positive impact on the market growth.
Purchase Report Directly @ http://www.reportsnreports.com/purchase.aspx?name=917422
According to the report, one driver in market is growing adoption of PET/CT hybrid imaging. The market
witnesses a growing adoption of PET/CT hybrid imaging technology, owing to its advantages such as
early diagnosis, accurate disease staging, and effective response to the treatment of chronic conditions
such as cancer.
The combined PET/CT scans provide images that pinpoint the anatomic location of metabolic activity of
an individual. Also, PET/CT is the gold standard for oncology imaging and vendors are improving the
technological capabilities of PET/CT hybrid imaging system. This will further improve the adoption rates
worldwide. Some of the new technological capabilities include more precise measurement for better
differentiation and measurement of tumors, increased data storage capabilities for oncologists to track
tumor developments, and less patient movement. Vendors are also providing low-cost PET/CT hybrid
imaging systems like the PET/CT machines at around $1.2 million-$2.3 million. Such advantages increase
the adoption rate of PET/CT hybrid imaging systems. Also, PET/CT represents one of the medical imaging
modalities with the largest growth.
For More Information Inquire @
http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=917422
Further, the report states that one challenge in market is high-cost of hybrid imaging devices coupled
with limited reimbursements. The high-cost of hybrid imaging devices will not only hinder the adoption
rates but will also drive the physicians to opt for low-cost conventional imaging systems. For instance,
the cost of SPECT gamma camera ranges from $0.4 million to $0.6 million, while a PET/CT scanner costs
about $2 million.